You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)

Docket ⤷  Sign Up Date Filed 2019-03-01
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand None Referred To Christopher J. Burke
Parties INTELGENX TECHNOLOGIES CORP.
Patents 6,159,498; 6,200,604; 6,264,981; 6,696,066; 6,759,059; 7,579,019; 8,147,866; 8,703,177; 9,597,288; 9,655,843; 9,901,539
Attorneys Howard W. Levine
Firms Morris, Nichols, Arsht & Tunnell LLP
Link to Docket External link to docket
Small Molecule Drugs cited in BioDelivery Sciences International, Inc. v. Chemo Research, S.L.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in BioDelivery Sciences International, Inc. v. Chemo Research, S.L.
The biologic drug covered by the patents cited in this case is ⤷  Sign Up .

Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2019-03-01 1 Exhibit A-C crosslinked and/or plasticized in order to alter 6,159,498, U.S. Pat. No. 5,800,832, U.S. Pat. No. 6,585,…0168147 A1 7/2010 Chapleo et al. 6,159,498 A 12/2000 Tapolsky et al. …Pat. its dissolution kinetics. No. 6,159,498, U.S. Pat. No. 5,800,832, U.S. Pat. No. … (12) United States Patent (10) Patent No.: …experienced mucosal irrita including, patents, patent applications, articles, books, trea tion External link to document
2019-04-19 11 Answer to Complaint invalidity of U.S. Patents Nos. 8,147,866 (“the ’866 patent”), 9,655,843 (“the ’843 patent”), and 9,901,539…noninfringement of U.S. Patent Nos. 8,147,866 (“the ’866 patent”), 9,655,843 (“the ’843 patent”), and 9,901,539…COUNT I FOR PATENT INFRINGEMENT (Infringement of U.S. Patent No. 8,147,866 (“the ’866…,539 (“the ’539 patent”) (collectively, “the Patents-in-Suit”). 1 Plaintiffs’…this purports to be an action for patent infringement under the patent laws of the United States, Title External link to document
2020-01-06 121 Exhibit A-D International Patent Application Publication WO 00/62764 (“Yates”) x U.S. Patent No. 6,159,498 (“Tapolsky… (ii) Tapolsky II U.S. Patent No. 6,159,498 (“Tapolsky II”) issued on December 12, 2000… of U.S. Patent No. 9,655,843 (“the ’843 patent”), and claims 1-7 and 9-22 of U.S. Patent No. 9,901,539…the asserted patents or any related patent in any other forum or the United States Patent and Trademark… x U.S. Patent No. 4,713,243 x U.S. Patent No. 4,784,858 x U.S. Patent No. 5,780,047 External link to document
2020-01-17 134 Exhibit E-I asserted U.S. Patent Nos. 8,147,866 (“the ’866 patent”); 9,655,843 (“the ’843 patent”); and 9,901,539…are not indefinite. I. U.S. Patent No. 8,147,866 Claim Term … U.S. Patent No. 8,147,866 Claim(s) Term/Phrase Defendants…'s U.S. Patent Number 6,175,014, 7 hereinafter the "'014 Patent," and plaintiff…, 2001, the U.S. Patent and Trademark 18 Office issued the '014 Patent, entitled "Process External link to document
2020-04-15 243 Redacted Document of U.S. Patent No. 7,579,019 (including applications that led to U.S. Patent No. 7,579,019 and any … of U.S. Patent No. 7,579,019 (including applications that led to U.S. Patent No. 7,579,019 and any foreign… discovery concerning U.S. Patent No. 7,579,019 (“the ’019 Patent”), even though BDSI asserts…Osborne are the named inventors of U.S. Patent No. 7,579,019, a patent that is not at issue in the present…subject.” (U.S. Patent No. 7,579,019 at Claim 1). BDSI caused the ’019 patent to be listed in External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.